Lv6
2356 积分 2023-08-14 加入
Clinical feasibility of curative surgery after nab-paclitaxel plus gemcitabine-cisplatin chemotherapy in patients with locally advanced cholangiocarcinoma
5小时前
待确认
Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) – a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)– the AIO/ CALGP/ ACO- GAIN-trial –
15小时前
待确认
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
8天前
已完结
Cholangiocarcinoma 2026
9天前
已关闭
Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma
1个月前
已完结
Current standards and future perspectives in adjuvant treatment for biliary tract cancers
1个月前
已完结
Cancer burden and control in China: landscape, trends and challenges
2个月前
已完结
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study
2个月前
已完结
Donafenib plus immune checkpoint inhibitors with or without oral fluorouracil chemotherapy drugs (S-1/capecitabine) for patients with resected high-risk biliary tract tumor: A multi-center retrospective study
3个月前
已完结
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
3个月前
已完结
皖公网安备34019202002308
